NIO: 15% | Nio shares are trading higher after investors agreed to invest an aggregate of 3.3 billion yuan in its Nio China subsidiary while the company agreed to invest 10 billion yuan.

PRME: 33% | Prime Medicine Enters Strategic Research Collaboration And License Agreement With Bristol Myers Squibb; Prime Medicine To Receive $110M Upfront, With Potential For More Than $3.5B In Milestones

BL: 4% | BlackLine shares are trading higher after Morgan Stanley upgraded the stock from Equal-Weight to Overweight and raised its price target from $60 to $70.